Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which spacer works best for wheezing tots? new study has answers

NCT ID NCT03900494

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two different spacer devices (valved holding chambers) used to give asthma medicine to children aged 6 months to 4 years with sudden wheezing. 80 children from Finnish hospitals took part. The goal was to see if one spacer worked better for symptom relief, hospital stays, and side effects. The results help doctors choose the best device for treating breathing trouble in young kids.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Apr 2019

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 months to 4 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- Children (age 0.5-4 years) seeking medical aid due to respiratory distress caused by bronchial obstruction Exclusion Criteria: * requiring immediate admission to inpatient treatment in hospital * peripheral capillary oxygen saturation below 85% on admission * physician-confirmed pneumonia * inspiratory crackles on lung auscultation * croup * airway foreign body * impaired renal or liver function * immune compromised patient * general condition affecting the study per investigation judgement * bronchopulmonary dysplasia * long-acting beta-adrenoceptor agonist treatment * recruited to the ongoing study earlier * have been enrolled in a clinical trial within 30 days prior to admission * not willing to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bronchial obstruction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kuopio University Hospital

    Kuopio, 70210, Finland

  • Oulu University Hospital

    Oulu, 90220, Finland

  • Tampere University Hospital

    Tampere, 33521, Finland

  • Terveystalo Tampere

    Tampere, 33100, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.